These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9065966

  • 1. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK, Vegt M, Nolen WA.
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
    Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF.
    J Clin Psychopharmacol; 1991 Aug; 11(4):254-6. PubMed ID: 1918424
    [Abstract] [Full Text] [Related]

  • 3. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
    Thase ME, Kupfer DJ, Jarrett DB.
    J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC, Harto-Truax N, Bauer N.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F, Wolfersdorf M.
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [Abstract] [Full Text] [Related]

  • 6. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 7. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC, Mayo JP, Gillette GM, Little KY, Mason GA.
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT.
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [Abstract] [Full Text] [Related]

  • 9. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD, Berwish N.
    J Clin Psychopharmacol; 1987 Aug; 7(4):238-42. PubMed ID: 3305592
    [Abstract] [Full Text] [Related]

  • 10. T3 augmentation of antidepressant treatment in T4-replaced thyroid patients.
    Cooke RG, Joffe RT, Levitt AJ.
    J Clin Psychiatry; 1992 Jan; 53(1):16-8. PubMed ID: 1737734
    [Abstract] [Full Text] [Related]

  • 11. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.
    Gwirtsman HE, Szuba MP, Toren L, Feist M.
    Psychopharmacol Bull; 1994 Jan; 30(2):157-64. PubMed ID: 7831449
    [Abstract] [Full Text] [Related]

  • 12. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M, Erfurth A.
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [Abstract] [Full Text] [Related]

  • 13. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA, Mesones HL, Brengio F.
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T, Struck M, Laux G.
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [Abstract] [Full Text] [Related]

  • 15. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ, Stewart JW, Nunes EN, Quitkin FM.
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [Abstract] [Full Text] [Related]

  • 16. Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients.
    Posternak MA, Zimmerman M.
    J Clin Psychiatry; 2001 Feb; 62(2):135-42; quiz 143. PubMed ID: 11247104
    [Abstract] [Full Text] [Related]

  • 17. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML, Deister A, Laux G, Staberock U, Höflich G, Möller HJ.
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [Abstract] [Full Text] [Related]

  • 18. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 May; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

  • 19. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
    Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D.
    J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
    [Abstract] [Full Text] [Related]

  • 20. Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine.
    Evans DL, Strawn SK, Haggerty JJ, Garbutt JC, Burnett GB, Pedersen CA.
    J Clin Psychiatry; 1986 Oct; 47(10):521-2. PubMed ID: 3759918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.